- Home
- BIVI vs NCRA Comparison
BIVI vs NCRA Comparison
Compare BIVI & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- NCRA
- Stock Information
- Founded
- BIVI 2013
- NCRA 2002
- Country
- BIVI United States
- NCRA Taiwan
- Employees
- BIVI N/A
- NCRA N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- BIVI Health Care
- NCRA Consumer Staples
- Exchange
- BIVI Nasdaq
- NCRA Nasdaq
- Market Cap
- BIVI 18.8M
- NCRA 16.8M
- IPO Year
- BIVI N/A
- NCRA N/A
- Fundamental
- Price
- BIVI $0.85
- NCRA $0.99
- Analyst Decision
- BIVI Strong Buy
- NCRA
- Analyst Count
- BIVI 1
- NCRA 0
- Target Price
- BIVI $30.00
- NCRA N/A
- AVG Volume (30 Days)
- BIVI 204.2K
- NCRA 20.2K
- Earning Date
- BIVI 05-13-2025
- NCRA 05-14-2025
- Dividend Yield
- BIVI N/A
- NCRA N/A
- EPS Growth
- BIVI N/A
- NCRA N/A
- EPS
- BIVI N/A
- NCRA N/A
- Revenue
- BIVI N/A
- NCRA $20,483,694.00
- Revenue This Year
- BIVI N/A
- NCRA N/A
- Revenue Next Year
- BIVI N/A
- NCRA N/A
- P/E Ratio
- BIVI N/A
- NCRA N/A
- Revenue Growth
- BIVI N/A
- NCRA N/A
- 52 Week Low
- BIVI $0.62
- NCRA $0.70
- 52 Week High
- BIVI $7.50
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- BIVI 43.28
- NCRA 54.10
- Support Level
- BIVI $0.75
- NCRA $0.84
- Resistance Level
- BIVI $0.88
- NCRA $1.00
- Average True Range (ATR)
- BIVI 0.11
- NCRA 0.08
- MACD
- BIVI 0.02
- NCRA 0.00
- Stochastic Oscillator
- BIVI 81.78
- NCRA 86.24
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.